University of Cincinnati
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Cincinnati sits in the top decile of US sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count).
University of Cincinnati: 245 sponsored US clinical trials, 34 recruiting.
University of Cincinnati sponsors 245 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 172 completed. 65 of these trials are in Phase 3-4 (later-stage) and 56 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 9 trials.
Top-decile sponsor footprint
University of Cincinnati ranks in the top decile of sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
172 of 189 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
245 total, page 1 of 5
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
NCT07528638
Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment
NCT07494890
Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
NCT07447895
Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth
NCT07464886
Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
NCT07231588
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
NCT07213934
Early Neuromodulation in Traumatic Brain Injury
NCT06871124
Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
NCT06795451
Post-Stroke Sensory Reweighting on Walking and Balance Outcomes
NCT06727097
Image Detection of Impaired Microcirculatory Reperfusion
NCT07099599
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
NCT06574022
Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia
NCT06933095
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
NCT06416007
Effect of C-peptide on Hypoglycemic Counterregulation
NCT06470295
HIT-Stroke Trial 2
NCT06268041
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
NCT05911568
Simplified Ultrasound Feedback for Speech Remediation
NCT06366256
K01 Impacts of Lingual Endurance Exercise
NCT06072924
Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws
NCT06409559
Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
NCT05560477
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
NCT06163482
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)
NCT05337618
Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform
NCT05876208
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
NCT05338697
Neuroimaging Reveals Treatment-related Changes in DLD
NCT05268341
Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
NCT04623099
Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
NCT04389749
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
NCT04245748
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
NCT04245436
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
NCT04221997
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
NCT05973799
Cricopharyngeal Dysfunction and Esophageal Diverticulum
NCT03187925
Study of Letrozole in Recurrent Gliomas
NCT03122197
Safety and Durability of Sirolimus for Treatment of LAM
NCT02432560
tAN for PTSD and OUD in Buprenorphine Therapy
NCT06130501
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
NCT05902533
Let's K-Talk - HPV Study for Ethnic Koreans
NCT05884697
Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)
NCT05304078
Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.
NCT05251454
Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease
NCT05115331
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
NCT04594772
Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC
NCT04340258
The Wright Center of Innovation Imaging Archive
NCT05074537
Proton Boost in Prostate Cancer
NCT03564275
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
NCT03150914
Early Intervention in Cognitive Aging
NCT02751866
Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
NCT02119065
Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics
NCT01719016
3 Tesla MRI in Patients With Bladder Cancer
NCT00938145
Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III
NCT00930280
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 33 |
| Phase 3 | 19 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the University of Cincinnati pipeline
34 recruiting of 245 indexed (14% open); 172 completed (70%).
Phase mix: 65 late (III/IV) vs 56 early (I/II) (balanced across stages).
Top condition: Stroke (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Cincinnati: open-pipeline peers nationwide
Peers matched on 245 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 245 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- BeiGene · 14% recruiting · 65 trials
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
Related
What to do with this University of Cincinnati page
245 registered trials is a research-attention snapshot, not an endorsement of University of Cincinnati or any single study.
- 34 of University of Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition University of Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Cincinnati pipeline card: 245 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.